903,103 Shares in ASP Isotopes Inc. $ASPI Purchased by Sara Bay Financial

Sara Bay Financial purchased a new stake in ASP Isotopes Inc. (NASDAQ:ASPI) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 903,103 shares of the company’s stock, valued at approximately $8,688,000. ASP Isotopes makes up about 2.4% of Sara Bay Financial’s portfolio, making the stock its 10th largest position. Sara Bay Financial owned about 0.98% of ASP Isotopes as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of ASPI. B. Riley Wealth Advisors Inc. acquired a new stake in shares of ASP Isotopes during the 2nd quarter worth approximately $121,000. Marex Group plc acquired a new position in shares of ASP Isotopes in the second quarter valued at $552,000. FORA Capital LLC bought a new position in ASP Isotopes in the second quarter worth $107,000. Tower Research Capital LLC TRC lifted its position in ASP Isotopes by 96.7% in the second quarter. Tower Research Capital LLC TRC now owns 10,890 shares of the company’s stock worth $80,000 after purchasing an additional 5,353 shares during the period. Finally, Shay Capital LLC acquired a new stake in ASP Isotopes during the second quarter worth $320,000. Institutional investors own 16.80% of the company’s stock.

Insiders Place Their Bets

In other news, Chairman Paul Elliot Mann sold 162,153 shares of the firm’s stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $5.75, for a total transaction of $932,379.75. Following the completion of the sale, the chairman owned 7,759,538 shares of the company’s stock, valued at approximately $44,617,343.50. This trade represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Robert Ainscow sold 8,438 shares of the business’s stock in a transaction that occurred on Monday, December 8th. The stock was sold at an average price of $6.20, for a total value of $52,315.60. Following the completion of the transaction, the chief executive officer directly owned 1,546,255 shares in the company, valued at $9,586,781. The trade was a 0.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 512,091 shares of company stock valued at $3,699,245. 14.40% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, December 15th. Cantor Fitzgerald initiated coverage on shares of ASP Isotopes in a research report on Thursday, December 4th. They set an “overweight” rating and a $13.00 target price on the stock. Canaccord Genuity Group reissued a “buy” rating and issued a $11.00 target price on shares of ASP Isotopes in a research note on Monday, November 24th. Finally, Loop Capital set a $15.00 price target on shares of ASP Isotopes in a research note on Monday, October 27th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $13.00.

ASP Isotopes Stock Up 5.0%

Shares of NASDAQ ASPI opened at $6.08 on Friday. The stock has a market cap of $673.91 million, a PE ratio of -4.68 and a beta of 3.41. The business has a fifty day moving average of $8.03 and a two-hundred day moving average of $8.63. ASP Isotopes Inc. has a 52-week low of $3.65 and a 52-week high of $14.49. The company has a debt-to-equity ratio of 1.04, a quick ratio of 6.10 and a current ratio of 6.14.

ASP Isotopes (NASDAQ:ASPI) last posted its earnings results on Wednesday, November 19th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.05). The firm had revenue of $4.89 million during the quarter, compared to the consensus estimate of $2.25 million. ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%. As a group, equities research analysts expect that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.